Global Artificial Intelligence in Diabetes Management Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Product;

Glucose Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices, and Others.

By Techniques;

Case-based Reasoning and Intelligent Data Analysis.

By End-Use;

Hospitals, Clinics, Home Care Settings, and Research Institutes.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn118610021 Published Date: October, 2024 Updated Date: December, 2024

Introduction

Global Artificial Intelligence in Diabetes Management Market (USD Million), 2020 - 2030

In the year 2023, the Global Artificial Intelligence in Diabetes Management Market was valued at USD 849.09 million. The size of this market is expected to increase to USD 5,484.77 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 30.5%.

The Global Artificial Intelligence in Diabetes Management Market represents a transformative intersection of healthcare and technology, leveraging advanced algorithms and data analytics to revolutionize the management and treatment of diabetes. With diabetes emerging as a significant global health concern, characterized by rising prevalence rates and associated healthcare costs, the integration of artificial intelligence (AI) offers promising solutions to address the complexities of this chronic condition.

Diabetes, a metabolic disorder characterized by elevated blood sugar levels, poses significant challenges for patients, healthcare providers, and healthcare systems worldwide. Effective diabetes management requires continuous monitoring of blood glucose levels, personalized treatment plans, lifestyle modifications, and timely interventions to prevent complications such as cardiovascular disease, kidney failure, and neuropathy. The manual interpretation of vast amounts of patient data and the variability in individual responses to treatment present significant hurdles in achieving optimal outcomes.

Artificial intelligence technologies, including machine learning, deep learning, and predictive analytics, are increasingly being deployed to augment traditional approaches to diabetes management. These AI-driven solutions analyze diverse datasets, including blood glucose levels, insulin dosages, dietary habits, physical activity, genetic predispositions, and medical histories, to generate actionable insights and personalized recommendations for patients and healthcare providers.

The market encompasses a wide range of AI-powered tools and platforms, including smartphone apps, wearable devices, continuous glucose monitoring systems, predictive analytics software, and virtual assistants. These technologies empower individuals with diabetes to proactively monitor their health, make informed lifestyle choices, adhere to treatment regimens, and achieve better glycemic control, thereby reducing the risk of long-term complications and improving quality of life.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Techniques
    3. Market Snapshot, By End-Use
    4. Market Snapshot, By Region
  4. Global Artificial Intelligence in Diabetes Management Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing diabetes prevalence
        2. Demand for personalized healthcare
        3. Rising healthcare investments
        4. Emphasis on preventive care
        5. Wearable devices and mobile apps adoption
      2. Restraints
        1. Data privacy concerns
        2. Interoperability challenges
        3. Regulatory hurdles
        4. Limited AI access in some regions
        5. Limited reimbursement
      3. Opportunities
        1. AI healthcare solution expansion
        2. Telemedicine and remote monitoring uptake
        3. AI-driven predictive analytics growth
        4. Personalized treatment plans
        5. EHR AI integration
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Artificial Intelligence in Diabetes Management Market, By Product, 2020 - 2030 (USD Million)
      1. Glucose Monitoring Devices
      2. Diagnostic Devices
      3. Insulin Delivery Devices
      4. Others
    2. Global Artificial Intelligence in Diabetes Management Market, By Techniques, 2020 - 2030 (USD Million)
      1. Case-based Reasoning
      2. Intelligent Data Analysis
    3. Global Artificial Intelligence in Diabetes Management Market, By End Use, 2020 - 2030 (USD Million)
      1. Hospitals
      2. Clinics
      3. Home Care Settings
      4. Research Institutes
    4. Global Artificial Intelligence in Diabetes Management Market, By Geography, 2020-2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Abbott Laboratories
      2. Medtronic plc
      3. Dexcom, Inc.
      4. Roche Diabetes Care
      5. Insulet Corporation
      6. Livongo Health (now part of Teladoc Health)
      7. Glooko, Inc.
      8. Tidepool
      9. Bigfoot Biomedical
      10. Beta Bionics
      11. Diabeloop
      12. Voluntis
      13. Senseonics Holdings, Inc.
      14. BetaCell, Inc.
      15. Rimidi
  7. Analyst Views
  8. Future Outlook of the Market